Market revenue in 2022 | USD 132.0 million |
Market revenue in 2030 | USD 233.2 million |
Growth rate | 7.4% (CAGR from 2022 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Enzymes |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Kits & Reagents, Enzymes |
Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Agilent Technologies Inc, Qiagen NV, New England Biolabs, Merck KGaA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Takara Bio Inc, LGC Group, Bausch Health Companies Inc, Promega |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular biology enzymes, reagents and kits market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 67.27% in 2022. Horizon Databook has segmented the Mexico molecular biology enzymes, reagents and kits market based on kits & reagents, enzymes covering the revenue growth of each sub-segment from 2018 to 2030.
Mexico is witnessing significant growth in biotechnology applications to human healthcare. In addition, the Mexican pharmaceutical industry is also witnessing a growth trend owing to presence of key market players in the country.
This growth trend has been favored by improvements in production practices, regulation, and certifications. This growing biotechnology and pharmaceutical market in the country is anticipated to exhibit growth owing to increasing use of molecular biology products.
Furthermore, initiatives related to genomics research are anticipated to further propel the market growth in the country. For instance, MX BioBank Project is funded by the UK Research Councils (RCUK), CONACYT Mexico, and the Newton Fund, which is aimed at building the largest biobank genetic resources in Latin America.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico molecular biology enzymes, reagents and kits market , including forecasts for subscribers. This country databook contains high-level insights into Mexico molecular biology enzymes, reagents and kits market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account